<scp>LMAN2</scp> Promotes Breast Cancer Tumorigenesis and Drug Resistance by Interacting With <scp>MAPK9</scp> via Activation of the <scp>MAPK</scp> Pathway
LMAN2 was a novel diagnostic and prognostic biomarker for BC that promotes chemoresistance via interaction with MAPK9 and activation of the MAPK pathway.
Authors
- Pei-jun Liu (ORCID: https://orcid.org/0009-0004-7404-6607)
- Wei Wang (ORCID: https://orcid.org/0009-0003-7539-9394)
- Feng Chen (ORCID: https://orcid.org/0000-0001-5836-0090)
- Pingping Li (ORCID: https://orcid.org/0000-0002-6397-1643)
- Juan Li (ORCID: https://orcid.org/0000-0003-0912-1813)
- Pengtao Liu
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70448
- Citations
- 2
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- National Natural Science Foundation of China